Related Experiment Video
Updated: May 25, 2026

05:53
Vitrification of Ovarian Cortex Tissue to Achieve a Glassy State of Aggregation
Published on: August 9, 2024
Ovarian cryopreservation
1Department of Obstetrics and Gynecology, Ewha Womans University, Seoul, Korea.
Minerva Medica
|January 27, 2012
Summary
Fertility preservation through ovarian tissue cryopreservation offers hope for patients with diseases risking ovarian failure. This experimental technique allows future transplantation, even for prepubertal girls.
Area of Science:
- Reproductive Medicine
- Oncology
- Cryobiology
Background:
- Malignant and non-malignant diseases pose a risk of ovarian failure.
- Fertility preservation is crucial for affected individuals, especially prepubertal girls.
- Ovarian cryopreservation and autotransplantation are emerging as viable strategies.
Purpose of the Study:
- To review the current strategies and outcomes of ovarian tissue cryopreservation for fertility preservation.
- To highlight the potential of ovarian autotransplantation following cancer treatment.
- To emphasize the importance of a multidisciplinary approach in fertility preservation.
Main Methods:
- Ovarian cortical tissue or whole ovary removal via laparoscopy.
- Application of slow freezing and vitrification techniques to preserve ovarian follicles.
- Orthotopic or heterotopic ovarian tissue transplantation after disease remission.
- Confirmation of malignant cell absence in the graft before autotransplantation.
Main Results:
- Ovarian cryopreservation provides a fertility preservation option when other methods are unsuitable.
- Laparoscopic removal allows for timely initiation of chemotherapy.
- Vitrification and slow freezing minimize follicular damage.
- Successful autotransplantation restores ovarian function post-treatment.
Conclusions:
- Ovarian cryopreservation and autotransplantation are promising experimental approaches for fertility preservation.
- This method is currently the sole option for fertility preservation in prepubertal females.
- A collaborative approach involving oncologists and reproductive endocrinologists is essential for successful outcomes.
